Providing 19,000** readers with the most important news of the day, the PharmaLive Daily Advantage is one of the most relied upon daily news sources in the pharmaceutical industry. All Daily Advantage subscribers are opt-in -- they have taken the time to personally sign up for the service -- and find significant value in the information they receive:



"The broad range of topics and the brief summaries. I subscribe to your other newsletters (Infectious Disease, Trial results, and others) and between all of them, I get plenty of information. I recently canceled my FirstWord subscription because PharmaLive is so much better."
Clinical Scientific Director, Cubist Pharmaceuticals

** (Listrak, September 2007)